Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente HIV CLINICAL TRIALS

Tipo Año Título Fuente
Artículo2018Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practiceHIV CLINICAL TRIALS
Artículo2017HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort studyHIV CLINICAL TRIALS
Artículo2015Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agentsHIV CLINICAL TRIALS
Artículo2012Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected PatientsHIV CLINICAL TRIALS
Letter2010Rapid Improvement in Fasting Lipids and Hepatic Toxicity After Switching From Didanosine/Lamivudine to Tenofovir/Emtricitabine in Patients With Toxicity Attributable to DidanosineHIV CLINICAL TRIALS
Artículo2009Impact of Observer Experience on the Reproducibility of Transient Elastometry in HIV/HCV Co-infected PatientsHIV CLINICAL TRIALS
Artículo2008Low Rate of Adverse Hepatic Events Associated with Fosamprenavir/Ritonavir-Based Antiretroviral RegimensHIV CLINICAL TRIALS
Artículo2008Very Low Prevalence and No Clinical Significance of Occult Hepatitis B in a Cohort of HIV-Infected Patients with Isolated Anti-HBc Seropositivity: The BHOI StudyHIV CLINICAL TRIALS
Artículo2006Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavirHIV CLINICAL TRIALS
Artículo2005Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naive patients: The VESD studyHIV CLINICAL TRIALS
Letter2003Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacyHIV CLINICAL TRIALS
Letter2003Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacyHIV CLINICAL TRIALS
Artículo2003Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patientsHIV CLINICAL TRIALS
Artículo2002Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-IIHIV CLINICAL TRIALS